Report #2885283

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

PMR; This serious case was reported by a consumer via interactive digital media and described the occurrence of polymyalgia rheumatica in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced polymyalgia rheumatica (Verbatim: PMR) (serious criteria GSK medically significant). The outcome of the polymyalgia rheumatica was not reported. The reporter considered the polymyalgia rheumatica to be related to Shingles vaccine. The company considered the polymyalgia rheumatica to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 07-FEB-2026 This case was reported by a patient via interactive digital media. The reporter finally persuaded to receive a shot (the one prior to this two-part shot) and subsequently developed PMR, an autoimmune disorder. The reporter noted that many people suffer from autoimmune diseases and expressed their belief that vaccines were the cause. The batch number was not provided and unable to contact the reporter.; Sender's Comments: A case of Polymyalgia rheumatica, an unknown time after receiving Shingles vaccine, in an adult female patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.